{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:22:57Z","timestamp":1787167377058,"version":"build-2736575974"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC 82101910"],"award-info":[{"award-number":["NSFC 82101910"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"2021 Shanghai Tenth People\u2019s Hospital Specialist Nursing Talent","award":["SYZKHLRC-C09"],"award-info":[{"award-number":["SYZKHLRC-C09"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate the impact of thyroid diseases (TDs) on the comorbidities incidence and immune system of patients with primary SS (pSS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 329 patients diagnosed with pSS who were admitted between January 2018 and September 2023 were evaluated. The patients were divided into two groups: those with and without TD. Clinical data at the onset of SS were recorded. Kaplan\u2013Meier method and Cox proportional hazards model were utilized for survival analysis. Flow cytometry and immunofluorescence measurements were used to analyse the lymphocyte subtypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 329 patients, 109 had TD. The most common types of TD were thyroid nodules (40.4%) and autoimmune thyroid diseases (AITDs) (28.4%). Patients with TD exhibited a significantly elevated incidence risk of malignancy (14.7% vs. 6.4%, P = 0.01) and osteoporosis (OP) (23.9% vs. 14.1%, P = 0.03). TD comorbidity was an independent risk factor of malignancy (HR 4.7, 95% CI 1.1\u201319.3, P = 0.03) and OP (HR 3.7, 95% CI 1.3\u201310.2, P = 0.01). Patients with SS and TD exhibited a higher ratio of programmed death-1 (PD1) + subsets of total CD3+ T cells, Th and Tc cells (all P = 0.03), as well as a lower ratio of unswitched memory B cells (P = 0.01) in peripheral blood. The ratio of PD1+ subsets of Th cells in salivary glands also exhibited a significantly increase in these patients compared with those without TD (P = 0.03) and the controls (P &amp;lt; 0.01).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The incidence risk of malignancy and OP was significantly elevated in pSS patients with TD. The significant elevated proportions of PD1+ T cells may influence the occurrence of this process.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae627","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T07:25:37Z","timestamp":1733988337000},"page":"2828-2835","source":"Crossref","is-referenced-by-count":3,"title":["Increased risk of malignancy and osteoporosis in primary Sj\u00f6gren\u2019s syndrome with thyroid diseases: potential implication from T cells"],"prefix":"10.1093","volume":"64","author":[{"given":"Xiaomeng","family":"Cui","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Shanghai Tenth People\u2019s Hospital, Tongji University , Shanghai,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Shanghai Tenth People\u2019s Hospital, Tongji University , Shanghai,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhen","family":"Sang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Shanghai Tenth People\u2019s Hospital, Tongji University , Shanghai,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Shanghai Tenth People\u2019s Hospital, Tongji University , Shanghai,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yikang","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Shanghai Tenth People\u2019s Hospital, Tongji University , Shanghai,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Shanghai Tenth People\u2019s Hospital, Tongji University , Shanghai,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Shanghai Tenth People\u2019s Hospital, Tongji University , Shanghai,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinying","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Shanghai Tenth People\u2019s Hospital, Tongji University , Shanghai,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,12,13]]},"reference":[{"key":"2025050316124858900_keae627-B1","doi-asserted-by":"crossref","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","article-title":"Sjogren syndrome","volume":"2","author":"Brito-Zeron","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2025050316124858900_keae627-B2","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1093\/rheumatology\/kev200","article-title":"Characterization of systemic disease in primary Sjogren\u2019s syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements","volume":"54","author":"Ramos-Casals","year":"2015","journal-title":"Rheumatology"},{"key":"2025050316124858900_keae627-B3","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1177\/0961203319857132","article-title":"Prognostic markers of lymphoma development in primary Sjogren syndrome","volume":"28","author":"Retamozo","year":"2019","journal-title":"Lupus"},{"key":"2025050316124858900_keae627-B4","doi-asserted-by":"crossref","first-page":"103084","DOI":"10.1016\/j.autrev.2022.103084","article-title":"Primary Sjogren\u2019s syndrome is associated with increased risk of malignancies besides lymphoma: a systematic review and meta-analysis","volume":"21","author":"Zhong","year":"2022","journal-title":"Autoimmun Rev"},{"key":"2025050316124858900_keae627-B5","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/1756-185X.13927","article-title":"Risk of malignancy in Korean patients with primary Sjogren\u2019s syndrome","volume":"23","author":"Kang","year":"2020","journal-title":"Int J Rheum Dis"},{"issue":"Suppl 126","key":"2025050316124858900_keae627-B6","first-page":"78","article-title":"Comorbidity and health care utilisation in persons with Sjogren\u2019s syndrome: a claims data analysis","volume":"38","author":"Albrecht","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"2025050316124858900_keae627-B7","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s00296-020-04615-3","article-title":"Prevalence and factors associated with osteoporosis and fragility fractures in patients with primary Sjogren syndrome","volume":"40","author":"Salman-Monte","year":"2020","journal-title":"Rheumatol Int"},{"key":"2025050316124858900_keae627-B8","first-page":"e28062","article-title":"Increased threat of thyroid diseases in patients with Sjogren\u2019s syndrome: a systematic review","volume":"14","author":"Kaur","year":"2022","journal-title":"Cureus J Med Science"},{"key":"2025050316124858900_keae627-B9","doi-asserted-by":"crossref","first-page":"e6737","DOI":"10.7717\/peerj.6737","article-title":"Increased risk of thyroid disease in patients with Sjogren\u2019s syndrome: a systematic review and meta-analysis","volume":"7","author":"Sun","year":"2019","journal-title":"PeerJ"},{"key":"2025050316124858900_keae627-B10","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/art.11460","article-title":"Thyroid dysfunction in primary Sjogren\u2019s syndrome: a long-term followup study","volume":"49","author":"D'Arbonneau","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2025050316124858900_keae627-B11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7861\/clinmedicine.14-2-157","article-title":"A retrospective study of long-term outcomes in 152 patients with primary Sjogren\u2019s syndrome: 25-year experience","volume":"14","author":"Abrol","year":"2014","journal-title":"Clin Med"},{"key":"2025050316124858900_keae627-B12","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s12016-018-8709-9","article-title":"Sjogren\u2019s syndrome and autoimmune thyroid disease: two sides of the same coin","volume":"56","author":"Anaya","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"key":"2025050316124858900_keae627-B13","first-page":"2389","article-title":"Clinical and histological features of patients with primary Sj\u00f6gren\u2019s syndrome and autoimmune thyroiditis: a national multicentre cross-sectional study","volume":"41","author":"Colafrancesco","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"2025050316124858900_keae627-B14","doi-asserted-by":"crossref","first-page":"100101","DOI":"10.1016\/j.waojou.2020.100101","article-title":"Chronic urticaria and thyroid pathology","volume":"13","author":"Gonzalez-Diaz","year":"2020","journal-title":"World Allergy Organ J"},{"key":"2025050316124858900_keae627-B15","first-page":"1210","article-title":"Is thyroid autoimmunity a predisposing factor for fibromyalgia? A systematic review and meta-analysis","volume":"40","author":"Park","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"2025050316124858900_keae627-B16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism Classification criteria for primary Sjogren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2025050316124858900_keae627-B17","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1161\/CIR.0000000000001104","article-title":"Emerging evidence on coronary heart disease screening in kidney and liver transplantation candidates: a scientific statement from the American Heart Association: endorsed by the American Society of Transplantation","volume":"146","author":"Cheng","year":"2022","journal-title":"Circulation"},{"key":"2025050316124858900_keae627-B18","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.mcna.2021.05.016","article-title":"Update on osteoporosis screening and management","volume":"105","author":"Anam","year":"2021","journal-title":"Med Clin North Am"},{"key":"2025050316124858900_keae627-B19","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/ard.2009.110619","article-title":"EULAR Sjogren\u2019s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren\u2019s syndrome","volume":"69","author":"Seror","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 124","key":"2025050316124858900_keae627-B20","first-page":"69","article-title":"The potential role of leflunomide in inhibiting vascular fibrosis by down-regulating type-II macrophages in Takayasu\u2019s arteritis","volume":"38","author":"Cui","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"2025050316124858900_keae627-B21","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s10067-005-1165-y","article-title":"Association of systemic and thyroid autoimmune diseases","volume":"25","author":"Biro","year":"2006","journal-title":"Clin Rheumatol"},{"key":"2025050316124858900_keae627-B22","first-page":"809","article-title":"Thyroid gland disorders in primary Sjogren\u2019s syndrome","volume":"63","author":"Punzi","year":"1996","journal-title":"Rev Rhum Engl Ed"},{"key":"2025050316124858900_keae627-B23","first-page":"3252","article-title":"Clinical and prognostic characteristics of 573 cases of primary Sjogren\u2019s syndrome","volume":"123","author":"Lin","year":"2010","journal-title":"Chinese Med J"},{"key":"2025050316124858900_keae627-B24","doi-asserted-by":"crossref","first-page":"e77210","DOI":"10.1371\/journal.pone.0077210","article-title":"Increased risk of primary Sjogren\u2019s syndrome in female patients with thyroid disorders: a longitudinal population-based study in Taiwan","volume":"8","author":"Lu","year":"2013","journal-title":"PLoS One"},{"key":"2025050316124858900_keae627-B25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MD.0b013e318181e6af","article-title":"Primary Sjogren syndrome in Spain: clinical and immunologic expression in 1010 patients","volume":"87","author":"Ramos-Casals","year":"2008","journal-title":"Medicine"},{"key":"2025050316124858900_keae627-B26","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2174\/1573397118666220127105546","article-title":"Autoimmune thyroid disease in primary Sjogren\u2019s syndrome: real-life screening practice and clinical outcomes","volume":"18","author":"Giron-Pillado","year":"2022","journal-title":"Curr Rheumatol Rev"},{"key":"2025050316124858900_keae627-B27","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1089\/thy.2023.0353","article-title":"Association between eight autoimmune diseases and thyroid cancer: a nationwide cohort study","volume":"34","author":"Park","year":"2024","journal-title":"Thyroid"},{"key":"2025050316124858900_keae627-B28","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cac2.12283","article-title":"The five major autoimmune diseases increase the risk of cancer: epidemiological data from a large-scale cohort study in China","volume":"42","author":"Zhou","year":"2022","journal-title":"Cancer Commun"},{"key":"2025050316124858900_keae627-B29","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/rheumatology\/kep404","article-title":"Incidence of malignancy in primary Sjogren\u2019s syndrome in a Chinese cohort","volume":"49","author":"Zhang","year":"2010","journal-title":"Rheumatology"},{"key":"2025050316124858900_keae627-B30","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1136\/annrheumdis-2011-200402","article-title":"Incidence of cancer in a nationwide population cohort of 7852 patients with primary Sjogren\u2019s syndrome in Taiwan","volume":"71","author":"Weng","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 126","key":"2025050316124858900_keae627-B31","first-page":"40","article-title":"Risk of non-Hodgkin\u2019s lymphoma and thyroid cancer in primary Sjogren\u2019s syndrome measured using the Korean Health Insurance Claims Database","volume":"38","author":"Ahn","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"2025050316124858900_keae627-B32","doi-asserted-by":"crossref","first-page":"102987","DOI":"10.1016\/j.autrev.2021.102987","article-title":"Cancer incidence in primary Sjogren\u2019s syndrome: data from the French hospitalization database","volume":"20","author":"Goulabchand","year":"2021","journal-title":"Autoimmun Rev"},{"key":"2025050316124858900_keae627-B33","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00296-012-2570-6","article-title":"The co-occurrence of Hashimoto thyroiditis in primary Sjogren\u2019s syndrome defines a subset of patients with milder clinical phenotype","volume":"33","author":"Caramaschi","year":"2013","journal-title":"Rheumatol Int"},{"key":"2025050316124858900_keae627-B34","doi-asserted-by":"crossref","first-page":"102316","DOI":"10.1016\/j.jaut.2019.102316","article-title":"Predictive markers of lymphomagenesis in Sjogren\u2019s syndrome: from clinical data to molecular stratification","volume":"104","author":"Kapsogeorgou","year":"2019","journal-title":"J Autoimmun"},{"key":"2025050316124858900_keae627-B35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s40618-017-0753-4","article-title":"Thyroid diseases and bone health","volume":"41","author":"Williams","year":"2018","journal-title":"J Endocrinol Invest"},{"key":"2025050316124858900_keae627-B36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11154-022-09778-x","article-title":"How does Hashimoto\u2019s thyroiditis affect bone metabolism?","volume":"24","author":"Wu","year":"2023","journal-title":"Rev Endocr Metab Dis"},{"key":"2025050316124858900_keae627-B37","doi-asserted-by":"crossref","first-page":"641560","DOI":"10.3389\/fendo.2021.641560","article-title":"Levothyroxine therapy in elderly patients with hypothyroidism","volume":"12","author":"Effraimidis","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025050316124858900_keae627-B38","first-page":"1719","article-title":"High prevalence of subclinical Sjogren\u2019s syndrome features in patients with autoimmune thyroid disease","volume":"24","author":"Coll","year":"1997","journal-title":"J Rheumatol"},{"key":"2025050316124858900_keae627-B39","doi-asserted-by":"crossref","first-page":"995895","DOI":"10.3389\/fimmu.2022.995895","article-title":"Exploiting the role of t cells in the pathogenesis of Sjogren\u2019s syndrome for therapeutic treatment","volume":"13","author":"An","year":"2022","journal-title":"Front Immunol"},{"key":"2025050316124858900_keae627-B40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cellimm.2016.09.009","article-title":"PD-1\/PD-L and autoimmunity: a growing relationship","volume":"310","author":"Zamani","year":"2016","journal-title":"Cell Immunol"},{"key":"2025050316124858900_keae627-B41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-981-15-3266-5_3","article-title":"Roles of PD-1\/PD-L1 pathway: signaling, cancer, and beyond","volume":"1248","author":"Ai","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"2025050316124858900_keae627-B42","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"2025050316124858900_keae627-B43","first-page":"403","article-title":"Hyperthyro\u00efdie et cancer du sein: y a-t-il une association? [Hyperthyroidism and breast cancer: is there a link?]","volume":"46","author":"Cordel","year":"2018","journal-title":"Gynecol Obstet Fertil Senol"},{"key":"2025050316124858900_keae627-B44","doi-asserted-by":"crossref","first-page":"102649","DOI":"10.1016\/j.autrev.2020.102649","article-title":"Hashimoto\u2019s thyroiditis: an update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation","volume":"19","author":"Ralli","year":"2020","journal-title":"Autoimmun Rev"},{"key":"2025050316124858900_keae627-B45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3390\/diagnostics10030149","article-title":"The influence of thyroid pathology on osteoporosis and fracture risk: a review","volume":"10","author":"Apostu","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"2025050316124858900_keae627-B46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3803\/EnM.2023.1701","article-title":"Evaluation and management of bone health in patients with thyroid diseases: a position statement of the Korean Thyroid Association","volume":"38","author":"Hong","year":"2023","journal-title":"Endocrinol Metab (Seoul)"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae627\/61219482\/keae627.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/5\/2828\/61219482\/keae627.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/5\/2828\/61219482\/keae627.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T16:13:05Z","timestamp":1746288785000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/5\/2828\/7923430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,13]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,12,13]]},"published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae627","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2024,12,13]]}}}